Physician profile
Nancy Conley
NPI 1790113587
$2,178.32
in general payments reported to CMS, 2019-2025
23 companies · $663 in 2025
The $663 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $347 · 2023: $363 · 2024: $661 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,678 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,678.03 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $341.43 | 2021-2025 | |
| Janssen Biotech, INC. | $226.35 | 2022-2025 | Tremfya, Simponi, Stelara |
| Arcutis Biotherapeutics, INC. | $167.84 | 2024 | Zoryve |
| Lilly USA, LLC | $153.30 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $137.03 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $131.02 | 2022-2025 | Ilumya, Absorica Ld, Winlevi |
| Genzyme Corporation | $127.86 | 2022-2024 | |
| Janssen Scientific Affairs, LLC | $123.12 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $118.15 | 2022-2023 | Dupixent |
| Ucb, INC. | $116.44 | 2024-2025 | Bimzelx |
| Amgen INC. | $99.82 | 2022-2025 | Otezla, Otezla |
| Pfizer INC. | $83.92 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $51.91 | 2023-2024 | |
| Botanix Sb INC | $44.49 | 2025 | Sofdra |
| Verrica Pharmaceuticals INC. | $44.23 | 2023-2025 | Ycanth |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $39.53 | 2024 | |
| Organon LLC | $39.45 | 2025 | Vtama |
| Journey Medical Corporation | $33.47 | 2024 | |
| Incyte Corporation | $28.18 | 2025 | Opzelura |
| Almirall LLC | $19.84 | 2024 | Klisyri |
| Biofrontera INC. | $19.21 | 2025 | |
| Strata Skin Sciences, INC. | $16.14 | 2025 | Xtrac |
| Dermavant Sciences, INC. | $15.59 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.